Literature DB >> 30228128

Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD.

Oleg V Kolupaev1, Trisha A Dant2, Hemamalini Bommiasamy1, Danny W Bruce1, Kenneth A Fowler1, Stephen L Tilley3, Karen P McKinnon1, Stefanie Sarantopoulos4, Bruce R Blazar5, James M Coghill1,3, Jonathan S Serody1,2,3.   

Abstract

Chronic graft-versus-host disease (cGVHD) causes significant morbidity and mortality in patients after allogeneic bone marrow (BM) or stem cell transplantation (allo-SCT). Recent work has indicated that both T and B lymphocytes play an important role in the pathophysiology of cGVHD. Previously, our group showed a critical role for the germinal center response in the function of B cells using a bronchiolitis obliterans (BO) model of cGVHD. Here, we demonstrated for the first time that cGVHD is associated with severe defects in the generation of BM B lymphoid and uncommitted common lymphoid progenitor cells. We found an increase in the number of donor CD4+ T cells in the BM of mice with cGVHD that was negatively correlated with B-cell development and the frequency of osteoblasts and Prrx-1-expressing perivascular stromal cells, which are present in the B-cell niche. Use of anti-DR3 monoclonal antibodies to enhance the number of donor regulatory T cells (Tregs) in the donor T-cell inoculum ameliorated the pathology associated with BO in this model. This correlated with an increased number of endosteal osteoblastic cells and significantly improved the generation of B-cell precursors in the BM after allo-SCT. Our work indicates that donor Tregs play a critical role in preserving the generation of B-cell precursors in the BM after allo-SCT. Approaches to enhance the number and/or function of donor Tregs that do not enhance conventional T-cell activity may be important to decrease the incidence and severity of cGVHD in part through normal B-cell lymphopoiesis.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30228128      PMCID: PMC6156893          DOI: 10.1182/bloodadvances.2017014977

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  46 in total

1.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

Authors:  Mathangi Srinivasan; Ryan Flynn; Andrew Price; Ann Ranger; Jeffrey L Browning; Patricia A Taylor; Jerome Ritz; Joseph H Antin; William J Murphy; Leo Luznik; Mark J Shlomchik; Angela Panoskaltsis-Mortari; Bruce R Blazar
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus.

Authors:  S L Nutt; P Urbánek; A Rolink; M Busslinger
Journal:  Genes Dev       Date:  1997-02-15       Impact factor: 11.361

3.  IL-7 mediates Ebf-1-dependent lineage restriction in early lymphoid progenitors.

Authors:  Panagiotis Tsapogas; Sasan Zandi; Josefine Åhsberg; Jenny Zetterblad; Eva Welinder; Jan Ingvar Jönsson; Robert Månsson; Hong Qian; Mikael Sigvardsson
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

4.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

Authors:  Joji Fujisaki; Juwell Wu; Alicia L Carlson; Lev Silberstein; Prabhakar Putheti; Rafael Larocca; Wenda Gao; Toshiki I Saito; Cristina Lo Celso; Hitoshi Tsuyuzaki; Tatsuyuki Sato; Daniel Côté; Megan Sykes; Terry B Strom; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

5.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

Authors:  Joseph Pidala; Brenda Kurland; Xiaoyu Chai; Navneet Majhail; Daniel J Weisdorf; Steven Pavletic; Corey Cutler; David Jacobsohn; Jeanne Palmer; Sally Arai; Madan Jagasia; Stephanie J Lee
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

Review 6.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

7.  A new murine model for bronchiolitis obliterans post-bone marrow transplant.

Authors:  Angela Panoskaltsis-Mortari; Kevin V Tram; Andrew P Price; Christine H Wendt; Bruce R Blazar
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

8.  Failure of B-cell differentiation in mice lacking the transcription factor EBF.

Authors:  H Lin; R Grosschedl
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

9.  Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer.

Authors:  Malcolm Logan; James F Martin; Andras Nagy; Corrinne Lobe; Eric N Olson; Clifford J Tabin
Journal:  Genesis       Date:  2002-06       Impact factor: 2.487

10.  Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.

Authors:  Angela Mensen; Korinna Jöhrens; Ioannis Anagnostopoulos; Sonya Demski; Maike Oey; Andrea Stroux; Philipp Hemmati; Jörg Westermann; Olga Blau; Friedrich Wittenbecher; Kamran Movassaghi; Martin Szyska; Sybill Thomas; Bernd Dörken; Carmen Scheibenbogen; Renate Arnold; Il-Kang Na
Journal:  Blood       Date:  2014-05-15       Impact factor: 22.113

View more
  6 in total

Review 1.  Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.

Authors:  Gérard Socié; Leslie S Kean; Robert Zeiser; Bruce R Blazar
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

Review 2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

Authors:  Kirsten M Williams; Yoshihiro Inamoto; Annie Im; Betty Hamilton; John Koreth; Mukta Arora; Iskra Pusic; Jacqueline W Mays; Paul A Carpenter; Leo Luznik; Pavan Reddy; Jerome Ritz; Hildegard Greinix; Sophie Paczesny; Bruce R Blazar; Joseph Pidala; Corey Cutler; Daniel Wolff; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Paul J Martin; Gerard Socie; Stefanie Sarantopoulos
Journal:  Transplant Cell Ther       Date:  2021-03-02

Review 3.  Developing role of B cells in the pathogenesis and treatment of chronic GVHD.

Authors:  Xiaoping Li; Qiangguo Gao; Yimei Feng; Xi Zhang
Journal:  Br J Haematol       Date:  2018-12-26       Impact factor: 6.998

Review 4.  Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.

Authors:  Chao Hong; Rong Jin; Xiaoqiu Dai; Xiaoming Gao
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

5.  Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.

Authors:  Teresa Lopes Ramos; Estefanía García-Guerrero; Teresa Caballero-Velázquez; Alfonso Rodríguez-Gil; Rocío Caracuel-García; Melanie Nufer; María José Robles-Frías; María Victoria Barbado; José A Pérez-Simón
Journal:  Bone Marrow Transplant       Date:  2021-09-23       Impact factor: 5.483

6.  CpG-Activated Regulatory B-Cell Progenitors Alleviate Murine Graft-Versus-Host-Disease.

Authors:  Viviane A Agbogan; Pauline Gastineau; Emmanuel Tejerina; Saoussen Karray; Flora Zavala
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.